Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets

Human blood contains 2 populations of dendritic cells (DCs): plasmacytoid and myeloid (mDC). mDCs are subdivided into 3 subsets using the surface markers CD16, CD1c, and BDCA-3. Their role as pathogen sentinels and adjuvant targets was tested by phenotypic and functional analysis. We show that mDC subsets are immature and express mRNA for most toll-like receptors (TLRs), except for TLR3 in CD16-mDCs. The most represented subsets, CD116- and CD1c-mDCs, are similarly responsive to all TLR agonists. Among 31 cytokines tested, both subsets produce CXCIL8 (IL-8)/tumor necrosis factor-alpha (TNF alpha)/IL-6/CCL3 (MIP-1a)/CCL4 (MIP-1 beta)/IL-1 beta. CXCL8 (IL-8) is the predominant cytokine produced by CD1c-mDCs on TILR engagement, whereas all other cytokines, particularly TNF-alpha, are secreted in 10-fold to 100fold higher amounts by CD16-mDCs. CD16mDCs cocultured with human umbilical vein endothelial cells induce a significantly higher production of CXCL10 (IP-10), granulocytemacrophage colony-stimulating factor, and granulocyte colony-stimulating factor than CD1c-mDCs. In addition, interieukin-3 and type I interferons are stimuli specifically for DC maturation rather than cytokine secretion, whereas TNF-alpha is almost ineffective in inducing either function, suggesting a mechanism of T-cell-DC crosstalk and of rapid induction of antigen-presenting cell function during viral infection rather than inflammation. In conclusion, CD16-mDCs show strong proinflammatory activity, whereas CD1c-mDCs appear to be mainly inducers of chernotaxis.